Indication
Esophageal Melanoma
1 clinical trial
2 products
1 drug
Clinical trial
A Randomized Phase II Trial of Adjuvant Nivolumab With or Without Cabozantinib in Patients With Resected Mucosal MelanomaStatus: Recruiting, Estimated PCD: 2024-12-19
Product
CabozantinibDrug
T-VECProduct
Placebo